| Teva Pharma AG - Piperacillin/Tazobactam-Teva 4.5 g, Pulver zur Herstellung einer Infusionslösung |
| 68062 | | 02 | | Piperacillin/Tazobactam-Teva 4.5 g | | Pulver zur Herstellung einer Infusionslösung | | J01CR05 | | Piperacillin and Beta-Lactamase Inhibitor | | 01.09.2020 | | |
|
| Composition |
| Praeparatio cryodesiccata: piperacillinum 4 g ut piperacillinum natricum, tazobactamum 0.5 g ut tazobactamum natricum, pro vitro. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | Lyophilisate | | | | | | Active Agent | Dose |
|---|
| Piperacilline | 4 g | | Tazobactame | 0.5 g |
|
|
|
